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Abstract: Oral squamous cell carcinomas (OSCCs) are the most common type of oral cancers, and high morbidity
and mortality are largely attributable to late-stage diagnosis. Despite significant advances in therapeutic strategies, the
5-year survival rate still remains low. Diallyl trisulfide (DATS), an oil-soluble organosulfur compound of garlic, was
recently reported for its anticancer effect on several types of cancer cells in vitro; however, these anticancer effects are
still unknown in human OSCC cells. In the present study, the effects of DATS on OSCC cell invasion in vitro were
investigated. Human OSCC cell lines (HSC-2 and Ca9-22 cells) were treated with DATS and examined for cell viability
by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay; the suppression of cell invasion
was demonstrated by transwell assay. Western blot was performed to detect the effect of DATS on the expression of
matrix metalloproteinase-9 (MMP-9) and the activation of v-akt murine thymoma viral oncogene homolog 1 (AKT1),
respectively. The results showed that DATS (at 40 μM, a nontoxic dose) and GM6001 inhibited (P < 0.05) the invasion
of OSCC cells, respectively, when compared to the DMSO control. DATS (at 40 μM) significantly decreased (P < 0.05)
the expression of MMP-9 and time-dependently inhibited (P < 0.05) the activation of AKT1, respectively. Moreover,
LY294002 also decreased (P < 0.05) the expression of MMP-9 in a dose-dependent manner. It was concluded that DATS
inhibits the invasion of OSCC cells by decreasing MMP-9 expression via the PI3K/AKT pathway.
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Introduction
Head and neck squamous cell carcinoma (HNSCC) is
the sixth most common cancer and a major cause of
morbidity and mortality globally. Over 500,000 cases
of HNSCC are diagnosed each year, and about 90% of
HNSCCs are oral squamous cell carcinomas (OSCCs)
(1,2). The associated high morbidity and mortality
are largely attributable to late-stage diagnosis and
the occurrence of second primary tumors. Although
diagnosis and treatment of OSCC have improved, the
survival rate has not increased substantially in recent
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years. The treatment of these types of oral cancers
includes surgery and/or radiotherapy, which are
often associated with loss of function, disfigurement,
and reduced quality of life (3). The development of
novel therapeutic agents targeting the malignant
behavior of these cancers is important to improve the
prognosis of treatment.
Garlic, which has a high content of organosulfur
compounds such as diallyl sulfide (DAS), diallyl
disulfide (DADS), and diallyl trisulfide (DATS) (4,5),
is considered to have medicinal properties in many

J. YANG, D. WEI, Z. WU, S. XU

areas. Among the garlic-derived allyl compounds,
DATS has been demonstrated to have an anticancer
effect on different types of human tumor cells,
including prostate cancer cells (6), lung cancer cells
(7), and skin cancer cells (8). However, little is known
about the functional role of DATS in the human
OSCC cell metastasis and the related molecular
mechanisms.
Metastasis is one of the major causes of mortality
in cancer patients and occurs as a highly coordinated
multistep process involving cell proliferation,
invasion, cell-cell and cell-matrix adhesion, and
remodeling of the extracellular matrix (ECM) (9).
Although a number of proteinases are involved
in the degradation of the ECM by cancer cells,
including matrix metalloproteinases (MMPs),
serine proteinase, and cathepsins (10), the secretion
of MMPs is crucial in cancer cell metastasis and is
deeply involved in cancer cell invasion (11). Among
human MMPs, MMP-9 is abundantly expressed in
various malignant tumors, including OSCC, and is
closely correlated with the invasive behavior of these
cancers (12-15).

Materials and methods
Materials
DATS was purchased from Fluka (Ronkonkoma,
NY, USA); LY294002 (PI3K-specific inhibitor) and
GM6001 (broad-spectrum matrix metalloproteinase
inhibitor) were purchased from CalbiochemNovabiochem (San Diego, CA, USA); and the
primary antibodies for MMP-9, AKT1, and phosphoAKT1 antibodies were purchased from Cell Signaling
Technology (Danvers, MA, USA).
Cell culture
OSCC cell lines (HSC-2 and Ca9-22 cells), derived
from human OSCCs, were purchased from the Cell
Bank of the Type Culture Collection of the Chinese
Academy of Sciences (Shanghai, China). All of the
cells were grown in Dulbecco’s modified Eagle’s
medium (DMEM) (Sigma-Aldrich Co., St. Louis, MO,
USA) supplemented with 10% fetal bovine serum,
100 U/mL penicillin, 100 μg/mL streptomycin, and
10 mM L-glutamine. All of the cells were cultured in
a humidified atmosphere of 5% CO2 at 37 °C.
MTT assay

It is well demonstrated that the expression of
MMP-9 in various tumor cells is tightly controlled,
and many extracellular stimuli trigger multiple
signaling cascades that are involved in the regulation
of MMP-9 expression and activity. Among these
pathways, the phosphatidylinositol 3-kinase (PI3K)/
v-akt murine thymoma viral oncogene homolog 1
(AKT1) is the best studied (16,17). Activated AKT
has been shown to be a frequent event in several
cancer types, such as breast, colon, and ovarian
cancer (18,19). Furthermore, it is reported that
kalopanax saponin A inhibits phorbol 12-myristate
13-acetate (PMA)-induced cell invasion by reducing
MMP-9 expression, mainly via the PI3K/AKT
signaling pathways in MCF-7 cells (20). However, it
is still unknown whether this signaling pathway is
involved in DATS-regulated MMP-9 expression in
OSCC cells.

The 3- (4,5 - dimethyl thiazol -2- yl) - 2,5 - diphenyl
tetrazolium bromide (MTT) viability assay was
performed as described. Briefly, the cells were seeded
into a 96-well plate with 0.5 × 104 cells/well. After
16 h of attachment, various concentrations of DATS
(0-320 μM) were applied to the cells in serum-free
DMEM and incubation was extended for another 24,
48, and 72 h, respectively. The cells were washed with
phosphate buffered saline, 200 μL of MTT (0.5 mg/
mL) was added to each well, and the cells were further
incubated for 4 h. The MTT solution was carefully
removed by aspiration and the formazan product was
dissolved in 150 mL of dimethyl sulfoxide (DMSO).
Absorbance was measured at 570 nm on a microplate
reader (BioTek Instruments, Winooski, VT, USA).
For each treatment concentration, 6 wells were used,
and the experiment was repeated 3 times.

In the present study, we used human OSCC
cell lines (HSC-2 and Ca9-22 cells) to investigate
the effects of the organosulfur compound of garlic,
DATS, on OSCC cell invasion during the metastasis
process. Our findings demonstrated that DATS
inhibits the invasion of OSCC cells by reducing
MMP-9 expression via the PI3K/AKT pathway.

Cell invasion was evaluated using a 24-Multiwell BD
Falcon FluoroBlok Insert System with 8.0-μm pore
polycarbonate filter inserts (BD Biosciences, San
Jose, CA, USA). The cells (8 × 104) were suspended in
0.5 mL of serum-free medium with or without 40 μM
DATS and were seeded into the upper compartment
of the invasion chamber coated with Matrigel.

Invasion assay
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Western blot analysis was carried out as described.
The collected cells were lyzed by sonication in
a buffer (50 mM HEPES, 0.1 M NaCl, 10 mM
EDTA, 4 mM sodium pyrophosphate, 10 mM
sodium fluoride, 1% Triton X-100, and protease
inhibitor cocktail). After centrifugation, protein
concentrations of the supernatant were determined
with bovine serum albumin (fraction V; Sigma,
St. Louis, MO, USA) as standards. The protein
samples were separated on 10% SDS-PAGE gels
and electrically transferred to polyvinylidene
fluoride membranes. Proteins on the membrane
were visualized using electrochemiluminescence
reagents. The immunoreactive signals were
analyzed by densitometry. Changes in the total and
phosphorylated AKT1 were quantified by scanning
densitometry (model GS 670; Bio-Rad, Hercules, CA,
USA). Data on MMP-9 expression were normalized
to glyceraldehyde-3-phosphate dehydrogenase
(GAPDH).
Statistical procedures
Values were expressed as the mean ± SEM of at least 3
independent experiments. Data were analyzed using
one-way ANOVA (SigmaStat; Jandel Co., San Rafael,
CA, USA). When an F-test was significant, the data
were compared with their respective controls by the
Bonferroni multiple comparison test or Student’s
t-test. P < 0.05 was considered to be statistically
significant.
Results
DATS reduces OSCC cell viability at high
concentrations
A cell viability assay was performed in response to
different concentrations of DATS (0-320 μM). The
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DATS suppresses the invasion of OSCC cell lines
To investigate the inhibitory effect of DATS on
the invasion of OSCC cells, the cells that invaded
through the Matrigel-coated polycarbonate filter
in the Boyden chamber were analyzed. After 16 h
of incubation, the cells showed a significantly (P <
A
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Western immunoblot analysis

MTT assay showed that at lower concentrations (040 μM), no clear effect was observed after 24-h and
48-h treatments of DATS. However, viability of the
cells was significantly (P < 0.05) decreased at lower
concentrations (20 μM) after 72 h of treatment
(Figure 1). Thus, for the following experiments, the
concentration of 40 μM DATS was chosen.
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The lower compartment was filled with complete
medium in the absence or presence of 40 μM DATS.
After 16 h, the cells that had been invaded on the
bottom of the inserts were fixed, stained, and counted
under a microscope. The numbers of invaded cells
were counted using the MetaMorph image analysis
program (Molecular Devices Inc., Sunnyvale, CA,
USA). Triplicate independent experiments were
done. To determine the role of MMP-9 on DATSregulated cell invasion, the specific inhibitor GM6001
(40 μM) was applied in this invasion assay.
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Figure 1. Cell viability response to DATS treatment. HSC-2
(A) and Ca9-22 (B) cells were treated with various
concentrations of DATS (0-320 μM) for 24, 48, and
72 h, respectively. Cell viability was determined
with MTT assay, and the graphs show the results
of 3 independent experiments. The results are
represented as a percentage of absorbance relative to
the control cells (100%). *Different (P < 0.05) from
their controls, respectively.
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0.05) decreased invasiveness response to 40 μM
DATS compared with the DMSO treatment in both
the HSC-2 and Ca9-22 cells (Figure 2). These results
demonstrated that DATS markedly suppressed the
invasion of oral squamous cell carcinoma cells.
Given the fact that MMP is deeply involved in the
cancer invasion process, we further observed the role
of MMPs on OSCC cell invasion through treatment
with its specific inhibitor, GM6001. The results showed
that the treatment of GM6001 at 40 μM sharply
suppressed the invasion of both HSC-2 and Ca9-22
cells (P < 0.05) (Figure 2). The results suggested that
the decreased ability of OSCC cell invasion might be
due to the proteolytic activities of MMPs.
A

DMSO

DATS

GM6001

DATS decreases the expression of MMP-9 and
inhibits the activation of AKT1 in OSCC cells
To further confirm the effects of DATS on the
expression of MMP-9, western blot analysis was
performed for both the MMP-9 and GAPDH gene.
As shown in Figure 3, after 24 h of treatment,
DATS significantly (P < 0.05) decreased the protein
expression of MMP-9 at 20 and 40 μM, respectively.
This decreased effect was also observed in the
GM6001-treated group, suggesting that GM6001
inhibited the expression of MMP-9 in these 2 cell
lines. Moreover, we detected the phosphorylation of
AKT1 after treatment with 40 μM of DATS. As shown
in Figure 4, DATS time-dependently (P < 0.05)
inhibited the activation of AKT1 in comparison with
time 0. This inactivation was maintained for at least
60 min. However, DATS did not alter the total AKT1
levels at any time point during the DATS treatments
studied (Figure 4).
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Figure 2. Effects of DATS on OSCC cell invasion using a
transwell assay. The cells suspended in serum-free
DMEM were overlaid in the upper chamber of each
transwell. After incubation with DATS (40 μM) or
GM6001 (40 μM) for 16 h, the penetrating cells
were stained with calcein AM and recorded under a
microscope mounted with a charge-coupled device
camera. A) Photographs depict the invasion of HSC2 and Ca9-22 cells; B) quantified data are expressed
as means ± SEM from 3 independent experiments. *
and # show difference (P < 0.05) from their controls,
respectively.

Control

20

40

GM

DATS (μM)

Figure 3. Effects of DATS on MMP-9 protein expression
in OSCC cells. The cells were cultured in culture
dishes until reaching 60%-70% confluence. They
were then treated with DATS (20 and 40 μM) and
GM6001 (40 μM) for 24 h, respectively. A) Proteins
were subjected to western blot analysis and detected
using an antibody against MMP-9 and GAPDH;
B) data normalized to GAPDH are expressed as
means ± SEM fold of the control from 3 individual
experiments. * and # show difference (P < 0.05) from
their controls, respectively.
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Inactivation of AKT1 is closely associated with
decreased MMP-9 expression
Several studies have indicated that signaling proteins,
including AKT1, are involved in the expression of
MMP-9. In order to evaluate whether the inhibition
of DATS on MMP-9 expression was through the
inactivation of AKT1, OSCC cells were treated
with a PI3K inhibitor (LY294002; 5 μM, 10 μM) for
24 h. Western blot results (Figure 5) showed that
LY294002 significantly (P < 0.05) reduced the MMP9 expression. The quantitative results showed that
this inhibitory effect has a dose-dependent manner.
The results revealed that the inhibition of MMP-9 by
DATS could partly occur through suppression of the
activation of AKT1.

A

Discussion
Within the last couple of years, interest in natural
compounds has grown greatly, especially in relation
to anticancer properties (21,22). Garlic has been
found to contain a large number of organosulfur
compounds, which possess anticancer properties.
Among the compounds, DATS has the most potent
chemopreventive and anticarcinogenic activities
(5-8). In the present study, we have provided
evidence that DATS was able to inhibit invasion
in human OSCC cells through AKT1-dependent
downregulation of MMP-9 expression, suggesting
that DATS might possess antimetastatic potential.
Several recent studies have demonstrated that
DATS is able to inhibit the growth of different types
of cancer cells, including prostate (6), lung (7), and
colon cancer cells (23), in culture. However, little is
known about the functional role of DATS in OSCC
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Figure 4. Effects of DATS on AKT1 phosphorylation in OSCC
cells. The cells were cultured in culture dishes until
reaching 60%-70% confluence. They were then treated
with 40 μM of DATS for 0-60 min. A) Proteins were
subjected to western blot analysis and detected using
an antibody against phospho-specific and total AKT1;
B) data normalized to total AKT1 are expressed as
means ± SEM fold of the control from 4 individual
experiments. * and # show difference (P < 0.05) from
their controls, respectively.
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Figure 5. Effects of LY294002 on MMP-9 protein expression in
OSCC cells. The cells were cultured in culture dishes
until reaching 60%-70% confluence. They were then
treated with 5 and 10 μM of LY294002 for 24 h. A)
Proteins were subjected to western blot analysis and
detected using an antibody against MMP-9 and
GAPDH; B) data normalized to GAPDH are expressed
as means ± SEM fold of the control from 4 individual
experiments. * and # show difference (P < 0.05) from
their controls, respectively.
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metastatic progression. Our present results indicated
that DATS significantly suppressed the viability of
both HSC-2 and Ca9-22 cells at the relatively higher
concentration of 80 μM. When these cells were treated
with DATS at nontoxic doses (40 μM), invasion was
significantly inhibited. These results implied that the
inhibitory effects of DATS on OSCC cell invasion
were not due to its cytotoxic effect.
Cancer metastasis is a complex multistep process,
in which cancer cells invade the basement membrane
and the ECM, and then migrate into new tissue. MMPs
have been implicated for invasion and metastasis
of cancer cells (24). It is well demonstrated that the
expression of MMP-9 is an important phenotypic
determinant of OSCC (25), and inhibition of MMP9 has been shown to suppress cell migration and
invasion by in vitro Matrigel invasion assay in a
couple of cancer cell lines, including OSCC cells (2628). Our current inhibition of MMP-9 using MMP’s
inhibitor, GM6001, significantly suppressed the
invasion of OSCC cells. Treatment with DATS at 20
μM and 40 μM for 24 h both robustly decreased the
expression of MMP-9. These results suggest that the
decrease of MMP-9 expression might be attributed
to the antiinvasion effect of DATS. The inhibitory
effect of DATS on MMP-9 may be, at least in part,
responsible for its antimetastatic potential.

the signaling pathway related to decreased MMP-9
expression induced by DATS in OSCC cells is still
unknown. Therefore, we examined the effect of DATS
on the activities of the PI3K/AKT signaling pathways.
The results showed that treatment with DATS timedependently inhibited AKT1 phosphorylation,
suggesting that the signaling pathways mediated by
PI3K/AKT were suppressed by DATS. Furthermore,
inhibition of the PI3K/AKT signaling pathway using
its specific inhibitor significantly decreased the
expression of MMP-9, suggesting that the DATSdecreased MMP-9 expression is partly mediated by
the PI3K/AKT pathway.
In conclusion, this preliminary investigation has
shown that the decrease of MMP-9 expression by
DATS is attributed to the inactivation of the PI3K/
AKT signaling pathways, and such a suppressive
effect might contribute to the inhibition of invasion
in human OSCC cell by DATS. These findings reveal a
new therapeutic potential for DATS in antimetastatic
therapy.
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The PI3K/AKT pathway has been suggested
to be highly involved in tumor cell invasion (29).
The induction of PI3K/AKT is involved in MMP-9
expression in different cell types (30,31). However,
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